|
|
|
|
Gene Therapy - Reports summarize gene therapy research from University of California
'A subset of G-protein coupled receptors (GPCRs), including the thrombin receptor (PAR1), elicits mitogenic responses.Thrombin also activates Ras homolog gene family member A (RhoA) and activating protein (AP-1) -mediated gene expression...
|
|
|
Independent association of extent of resection with survival in patients with malignant brain astrocytoma Clin
You can also purchase online an Individual or Institutional Subscription to this journal or buy one or more printed volumes.Independent association of extent of resection with survival in patients with malignant brain astrocytoma...
|
|
|
CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tu
- (NewsRx.com) -- Schering-Plough Corporation (NYSE:SGP) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of the intravenous ...
|
|
|
Supratentorial juvenile pilocytic astrocytoma in a young adult with Silver-Russell syndrome
American Journal of Epidemiology, 11/25/08 Pediatric Infectious Disease Journal, Supratentorial juvenile pilocytic astrocytoma in a young adult with Silver-Russell syndrome.
|
|
|
CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tu
/PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of the...
|
|
|
CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tu
Schering-Plough Receives CHMP Positive Opinion for TEMODAL(R) Intravenous Formulation and Oral TEMODAL Sachet Presentation -- Providing Potential New Treatment Options for EU Patients with Certain Primary Brain Tumors KENILWORTH, N.J., Dec....
|
|
|
Burzynski Research Institute, Inc. (BRI) Presents Promising Phase II Data on Malignant Glioma
- Today at the 13 Background Phase II Study in Anaplastic Astrocytoma In this Phase II clinical trial, ANP is administered daily on an outpatient basis, via an ambulatory infusion pump, to adult patients with newly-diagnosed anaplastic...
|
|
|
Thought Leaders from Burzynski Research Institute, Inc. Present Encouraging Data on Antineoplastons for Treatm
- Several thought leaders from the Burzynski Research Institute, Inc.(BRI) and the Burzynski Clinic (BC) in Houston, Texas are presenting at the 13 The early clinical data associated with antineoplastons are promising for patients...
|
|
|
Genetically modified tumor-targeted bacteria with reduced virulence
Title: United States Patent: 7,354,592 Inventors: Bermudes; David (Wallingford, CT), Low; Kenneth Brooks (Guilford, CT) Assignee: Vion Pharmaceuticals, Inc.(New Haven, CT), Yale University (New Haven, CT) Appl. No.: 11/064,533 Filed:...
|
|
|
Gene discovery could delay brain tumours
THE growth of deadly brain tumours could be halted or delayed after a gene technology breakthrough by Sydney researchers.Research funded by the Cure4Life foundation founded by renowned neurosurgeon Charles Teo found a gene that regulates...
|
